Company: INVUP
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001193
Chunk: 186

Company: Investview, Inc.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 8
Chunk 186
---
 (7) consecutive quarters thereafter.

In
addition to the cash consideration for the 2023 Purchased Shares, the Company also agreed to cover a limited amount of the legal fees
incurred by the 2023 Sellers in the transaction, as well as provide Mr. Romano and Ms. Raynor with a $250,000 expense allowance, payable
in installments, to cover legal fees and other expenses on a non-accountable basis, in connection with any matters that may arise in
which either or both of Mr. Romano and/or Ms. Raynor served as officers and directors of the Company. In return, Mr. Romano and Ms. Raynor
agreed to waive any future entitlement, if at all, to indemnification of costs and expenses, including legal fees under Nevada law or
otherwise arising from or relating to any period in which Romano or Raynor were officers and directors of the Company.

The
consideration paid for the Purchased Shares of $2,922,380 plus the $250,000 expense allowance was allocated to the share purchase for
a total of $3,172,380.

Purchase
of Company Shares in a Private Transaction

On
February 7, 2024, we closed on the purchase in a private transaction of shares of our common stock under the terms of a Stock Purchase
and Release Agreement, dated February 6, 2024 (the “2024 Agreement”). Under the 2024 Agreement, the Company repurchased for
surrender and cancellation a total of 472,374,710 shares of the Company’s common stock (the “2024 Purchased Shares”)
from Ryan Smith and Chad Miller and certain of their respective affiliates and family members (collectively, the “2024 Sellers”).
The 2024 Purchased Shares were purchased for an aggregate purchase price of $3,571,146, representing a price of $0.007559985 per share,
representing a discount of approximately 57.6% to the average market price at the time of the closing. One-eighth of the purchase price
was paid within seven (7) days of the closing, with the balance payable in a series of equal quarterly payments over seven (7) consecutive
quarters thereafter.

Director
Independence

Our
common stock is currently quoted on the OTCQB maintained by OTC Markets. The OTCQB does not require us to have independent members of
our Board of Directors. Accordingly, we do not identify